CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 57643-57923 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12d35c12218f230c49f4dc892814ba9f1037f251","sourcedb":"CORD-19","sourceid":"12d35c12218f230c49f4dc892814ba9f1037f251","text":"Agonist OX40 treatment at the time of vaccination elicits highly polyfunctional B8Rspecific CD8 T cells that persisted, specifically, in the lung tissue in high numbers for at least 18-months after secondary challenge with VACV and importantly, was independent of CD4 T cell help.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T36","span":{"begin":0,"end":280},"obj":"Sentence"}],"attributes":[{"subj":"T36","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T50630","span":{"begin":0,"end":280},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T50630","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T78","span":{"begin":141,"end":145},"obj":"Body_part"},{"id":"T79","span":{"begin":146,"end":152},"obj":"Body_part"}],"attributes":[{"id":"A78","pred":"uberon_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A79","pred":"uberon_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"subj":"T78","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T79","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#9fec93","default":true},{"id":"CORD-19-Sentences","color":"#ec93b9"},{"id":"CORD-19-PD-UBERON","color":"#93d3ec"}]}]}}